There is a need to improve LDL-c goal attainment in patients with high or very high CV risk. Many patients need additional therapies on top of statins to lower residual CV risk. Do CETP inhibitors have the potential to facilitate further CV risk reduction? In this series, three experts discuss the unmet needs in LDL-c lowering, provide novel insights on CETP inhibition, and explain what we have learned from trials with CETP inhibitors.
This course consists of 3 episodes. Watch all episodes, answer pre- and post-test questions, and start earning CME credits.
In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. 
Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for .75 AAPA Category 1 CME credits. Approval is valid until December 4, 2024. PAs should claim only the credit commensurate with the extent of their participation in the activity.
